GENE ONLINE|News &
Opinion
Blog

Special
Policy Lawsuit
Supreme Court Rejects Juno, Welcomes Amgen Back to Patent Discussions
2022-11-08
Special Kidney
Highlights of ASN Kidney Week 2022
2022-11-02
Special American Healthcare
35% of Americans May Avoid Seeking Care Due to Concerns Over Healthcare Prices
2022-10-31
Special Synthetic Biology
Leveraging Synthetic Biology, Microbiome-based Therapies Open Up Possibilities for Clinical Applications
2022-10-20
Special Synthetic Biology
Synthetic Biology: A Rising Interdisciplinary Field that Revolutionizes the Biomedical Industry
2022-10-19
Special biotech
Transforming Southern California Biotech Landscape: An Interview With SoCalBio CEO Ahmed Enany
2022-10-18
Go Prime Biomanufacturing
Will Biden’s Biomanufacturing Initiative Kill Korean Partnership?
2022-10-12
Special Healthcare
Walmart Branches Out into Clinical Trial Recruitment, Competing with CVS and Walgreens
2022-10-11
Special Nobel Prize
Svante Pääbo Wins Physiology or Medicine Nobel Prize for Human Evolution Discoveries
2022-10-06
Special Nobel Prize
Three Scientists Jointly Win Nobel Prize for Innovations in Click Chemistry
2022-10-06
Special Illumina
Bill Gates Speaks at the Illumina Genomics Forum
2022-10-01
Special IlluminaGlobal Events
Illumina Genomics Forum Kicks Off With A Conversation With President Barack Obama
2022-09-29
Trials & Approvals Biogen
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Special ESMO 2022
ESMO 2022: Promising Trials Highlights That Are Worth Following
2022-09-21
COVID-19 Omicron
The COVID-19 Pandemic: Is Omicron the Last Variant?
2022-09-16
1 … 6 7 8 9 10 … 21
LATEST
Biotech in Beauty: Engineered Skin Bacteria Designed To Treat Acne
2024-05-10
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Infinitopes’ Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
2024-05-09
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top